Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9MPE
|
||||
| Drug Name |
(S)-N-((R)-2-(benzyloxy)-1-cyanoethyl)-2-(2-(4-chlorophenoxy)-2-methylpropanamido)-4-methylpentanamide
|
||||
| Synonyms |
CHEMBL377553
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H32ClN3O4
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)C(C)(C)Oc1ccc(Cl)cc1)C(=O)N[C@@H](COCc2ccccc2)C#N
|
||||
| InChI |
InChI=1S/C26H32ClN3O4/c1-18(2)14-23(30-25(32)26(3,4)34-22-12-10-20(27)11-13-22)24(31)29-21(15-28)17-33-16-19-8-6-5-7-9-19/h5-13,18,21,23H,14,16-17H2,1-4H3,(H,29,31)(H,30,32)/t21-,23+/m1/s1
|
||||
| InChIKey |
AMJZLJJCJXONIE-GGAORHGYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.